Targeting FoxO1 with AS1842856 Suppresses Adipogenesis

What We Talk About When We Talk About Fat

(2014) Evan D. Rosen et al.   CELL

Mitochondrial alteration in type 2 diabetes and obesity: An epigenetic link

(2014) Zhiyong Cheng et al.   CELL CYCLE

Targeting mitochondrial alterations to prevent type 2 diabetes-Evidence from studies of dietary redox-active compounds

(2014) Zhiyong Cheng et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells

(2013) Caroline Diep et al.   CELL CYCLE

Tracking adipogenesis during white adipose tissue development, expansion and regeneration

(2013) Qiong A Wang et al.   NATURE MEDICINE

High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway

(2013) Rokhsana Mortuza et al.   PLoS One

Protocol for effective differentiation of 3T3-L1 cells to adipocytes

(2012) Katja Zebisch et al.   ANALYTICAL BIOCHEMISTRY

The AKTion in non-canonical insulin signaling

(2012) Zhiyong Cheng et al.   NATURE MEDICINE

Mitochondrial dysfunction in white adipose tissue

(2012) Christine M. Kusminski et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models

(2010) Zhiyong Cheng et al.   ANTIOXIDANTS & REDOX SIGNALING

Foxo1 in hepatic lipid metabolism

(2010) Zhiyong Cheng et al.   CELL CYCLE

(−) Epigallocatechin gallate suppresses the differentiation of 3T3-L1 preadipocytes through transcription factors FoxO1 and SREBP1c

(2010) Hyojung Kim et al.   CYTOTECHNOLOGY

Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice

(2010) T. Nagashima et al.   MOLECULAR PHARMACOLOGY

Insulin signaling meets mitochondria in metabolism

(2010) Zhiyong Cheng et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Mitochondrial (Dys)function in Adipocyte (De)differentiation and Systemic Metabolic Alterations

(2009) Aurélia De Pauw et al.   AMERICAN JOURNAL OF PATHOLOGY

FoxO1 Haploinsufficiency Protects Against High-Fat Diet-Induced Insulin Resistance With Enhanced Peroxisome Proliferator-Activated Receptor   Activation in Adipose Tissue

(2009) J. J. Kim et al.   DIABETES

Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay

(2009) Kevin Niswender   DIABETES OBESITY & METABOLISM

Forkhead transcription factor Foxo1 is essential for adipocyte differentiation

(2009) Keisuke Munekata et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor γ Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes

(2009) WuQiang Fan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Irs1 Branch of the Insulin Signaling Cascade Plays a Dominant Role in Hepatic Nutrient Homeostasis

(2009) S. Guo et al.   MOLECULAR AND CELLULAR BIOLOGY

Foxo1 integrates insulin signaling with mitochondrial function in the liver

(2009) Zhiyong Cheng et al.   NATURE MEDICINE

Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth Regulation

(2008) Xiaocheng C. Dong et al.   Cell Metabolism